Literature DB >> 35674891

High-Throughput Analysis to Identify Activators of Notch Signaling.

Rachael Guenter1, Jacob Eide2, Herbert Chen1, J Bart Rose1, Renata Jaskula-Sztul3.   

Abstract

The Notch pathway regulates many cellular functions in a context-dependent manner. Depending on the cell type, either the activation or inhibition of Notch signaling can influence many processes such as cellular proliferation, specification, differentiation, and survival. The activation of Notch signaling has been shown to have therapeutic advantages in some cancers, thus having a method to identify Notch-activating compounds is needed. In this chapter we outline a method for high-throughput analysis of potential Notch pathway activators in a pancreatic neuroendocrine tumor cell line as an example. We also include the steps for subsequent validation of results and preclinical testing.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cancer therapeutics; High-throughput analysis; Luciferase reporter plasmid; Notch activation; Notch pathway; Notch signaling

Mesh:

Substances:

Year:  2022        PMID: 35674891     DOI: 10.1007/978-1-0716-2201-8_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

2.  A pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma.

Authors:  Tabraiz A Mohammed; Kyle D Holen; Renata Jaskula-Sztul; Daniel Mulkerin; Sam J Lubner; William R Schelman; Jens Eickhoff; Herbert Chen; Noelle K Loconte
Journal:  Oncologist       Date:  2011-05-31

3.  Identification and validation of Notch pathway activating compounds through a novel high-throughput screening method.

Authors:  Scott N Pinchot; Renata Jaskula-Sztul; Li Ning; Noel R Peters; Mackenzie R Cook; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

4.  Hesperetin, a potential therapy for carcinoid cancer.

Authors:  Barbara Zarebczan; Scott N Pinchot; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Am J Surg       Date:  2011-03       Impact factor: 2.565

5.  Conservation of the Notch1 signaling pathway in gastrointestinal carcinoid cells.

Authors:  Muthusamy Kunnimalaiyaan; Kelly Traeger; Herbert Chen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-10       Impact factor: 4.052

6.  p53 homologue, p51/p63, maintains the immaturity of keratinocyte stem cells by inhibiting Notch1 activity.

Authors:  R Okuyama; E Ogawa; H Nagoshi; M Yabuki; A Kurihara; T Terui; S Aiba; M Obinata; H Tagami; S Ikawa
Journal:  Oncogene       Date:  2007-01-22       Impact factor: 9.867

7.  Suberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma.

Authors:  Li Ning; Renata Jaskula-Sztul; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Ann Surg Oncol       Date:  2008-06-18       Impact factor: 5.344

8.  Epidermal Notch1 loss promotes skin tumorigenesis by impacting the stromal microenvironment.

Authors:  Shadmehr Demehri; Ahu Turkoz; Raphael Kopan
Journal:  Cancer Cell       Date:  2009-07-07       Impact factor: 31.743

9.  Valproic acid induces Notch1 signaling in small cell lung cancer cells.

Authors:  Christopher S Platta; David Yü Greenblatt; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  J Surg Res       Date:  2008-04-10       Impact factor: 2.192

10.  Histone deacetylase inhibitor thailandepsin-A activates Notch signaling and suppresses neuroendocrine cancer cell growth in vivo.

Authors:  Samuel Jang; Andrew Janssen; Zviadi Aburjania; Matthew B Robers; April Harrison; Ajitha Dammalapati; Yi-Qiang Cheng; Herbert Chen; Renata Jaskula-Sztul
Journal:  Oncotarget       Date:  2017-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.